Tamar Kinaciyan | Medicine | Best Research Article Award

Dr. Tamar Kinaciyan | Medicine | Best Research Article Award

Department of Dermatotolgy, Medical University of Vienna | Austria

Author Profile

Scopus

Orcid ID

Early Academic Pursuits

Dr. Tamar Kinaciyan embarked on her medical and dermatological journey at the Medical University of Vienna, where she completed her dermatology board examination in 1996 and specialized in environmental medicine and clinical allergology. Her early academic roles included heading the Borrelia-Outpatient Clinic (1994–2000) and directing immune fluorescence microscopy and antigen-mapping laboratories for bullous and connective tissue diseases (1993–1998). She further strengthened her clinical research foundation through diplomas in dermatoscopy, clinical investigation, and lung function analysis, laying a solid groundwork for her career in pediatric dermatology and allergology.

Professional Endeavors

Dr. Kinaciyan’s professional trajectory spans nearly three decades, marked by leadership roles in both clinical and organizational settings. She serves as Head of the Allergy and Pediatric Dermatology Clinics at the Department of Dermatology, Medical University of Vienna, and leads multiple specialized centers, including ACARE, HAE, and UCARE. Her contributions extend to international collaboration through Ga2LEN ACARE Centers and to advocacy for women in science as founder and honorary president of the Women’s Science Network Medicine. She has also held numerous key roles in Austrian and European scientific societies, reflecting her commitment to both clinical excellence and professional mentorship.

Contributions and Research Focus

Dr. Kinaciyan’s research primarily focuses on hereditary angioedema, urticaria, mastocytosis, and pediatric dermatology, alongside investigations into food allergies, latex allergy, drug hypersensitivity, and eczema. She has led and participated in multiple clinical trials, EU projects, and Austrian national studies, including the Austrian Registry of Bradykinin-mediated Angioedema and studies on sublingual immunotherapy for birch pollen-related food allergies. Her work bridges clinical and translational research, advancing diagnostic and therapeutic approaches for rare and complex allergic and dermatologic conditions.

Impact and Influence

Her clinical and research expertise has significantly influenced European and global dermatology and allergology communities. Dr. Kinaciyan has chaired numerous congress sessions, contributed to guideline task forces, and served as an editorial board member for several high-impact journals, including the Journal of Exploration of Asthma & Allergy. Her mentorship and advocacy efforts, particularly through WNW-med, have empowered foreign-trained physicians and supported gender equity in medical sciences, establishing her as both a thought leader and a mentor.

Academic Citations

Dr. Kinaciyan has a strong publication record with 88 peer-reviewed, Medline-indexed articles, totaling an impact factor of 782.704 and an h-index of 28. Her contributions span original research, invited articles, book chapters, and case studies in prestigious journals and texts, reflecting her broad influence across allergology and dermatology.

Legacy and Future Contributions

Dr. Kinaciyan’s legacy lies in her dual commitment to advancing clinical dermatology and fostering the next generation of medical researchers. By integrating cutting-edge research with patient-centered care and promoting inclusive academic networks, she has set a standard for excellence in both practice and mentorship. Moving forward, her continued focus on hereditary angioedema, pediatric dermatology, and clinical allergology promises to deepen scientific understanding and improve patient outcomes globally.

Conclusion

Dr. Tamar Kinaciyan exemplifies a rare combination of clinical acumen, research innovation, and leadership. Her pioneering work in hereditary angioedema and pediatric dermatology, coupled with her dedication to professional development and mentorship, has left an indelible mark on the field. With a prolific publication record, numerous awards, and sustained international impact, she stands as a leading figure whose ongoing contributions continue to advance both science and patient care.

Notable Publications

“Diagnostic difficulties in pediatric annular dermatoses

  • Author: Doris Weiss; Philipp Weber; Amélie Hampel; Julia Tittes; Wolfgang Weninger; Tamar Kinaciyan
  • Journal: Wiener Medizinische Wochenschrift
  • Year: 2024

“The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation

  • Author: Buttgereit T; Aulenbacher F; Gutsche A; Kolkhir P; Weller K; Vera Ayala C; Magerl M; Farkas H; Grumach AS; Aygören-Pürsün E et al.
  • Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • Year: 2024

“Docetaxel‐induced symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing

  • Author: Amélie Hampel; Tamar Kinaciyan
  • Journal: Contact Dermatitis
  • Year: 2024

“Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

  • Author: Reshef A; Buttgereit T; Betschel SD; Caballero T; Farkas H; Grumach AS; Hide M; Jindal AK; Longhurst H; Peter J et al.
  • Journal: The Journal of allergy and clinical immunology
  • Year: 2024

“The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case.

  • Author: Riebenbauer K; Czerny S; Egg M; Urban N; Kinaciyan T; Hampel A; Fidelsberger L; Karlhofer F; Porkert S; Walochnik J et al.
  • Journal: PLoS neglected tropical diseases
  • Year: 2024

 

 

 

Cora Sternberg | Meta analysis | Outstanding Scientist Award

Dr. Cora Sternberg | Meta analysis | Outstanding Scientist Award

Weill Cornell Medicine | United States

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Dr. Cora Sternberg’s academic journey reflects her commitment to excellence from the outset. She completed her medical training with distinction and pursued advanced fellowships, including a Research Fellowship in Immunology at the National Institutes of Health (1976–1977). Her early academic roles as Teaching Assistant at Stanford and Mount Sinai, followed by Clinical Instructor at Cornell University, laid the foundation for her lifelong dedication to education and clinical research. Her Phi Beta Kappa distinction from the University of Pennsylvania marked the start of a career dedicated to innovation and leadership in oncology.

Professional Endeavors

Over four decades, Dr. Sternberg has held prestigious academic and clinical leadership roles. She was Chief of Medical Oncology at San Camillo-Forlanini Hospital in Rome and served as Professor at La Sapienza University, shaping Italy’s oncology community. Since 2018, she has been Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine and New York-Presbyterian. She has also served as a global faculty member at Temple University, Tufts University, and European institutions.

Contributions and Research Focus

Dr. Sternberg has pioneered groundbreaking research in prostate cancer, bladder cancer, and renal cell carcinoma. She was instrumental in developing practice-changing therapies such as abiraterone, enzalutamide, and darolutamide, significantly improving survival outcomes for prostate cancer patients. Her work in urothelial cancer led to the establishment of M-VAC chemotherapy and global adoption of immunotherapy protocols. She also contributed to the development of pazopanib and other targeted therapies in renal cell carcinoma. Recently, she has expanded her research focus to artificial intelligence in oncology, spearheading initiatives to integrate AI into therapeutic decision-making.

Impact and Influence

With over 546 publications, six textbooks, and more than 45,200 citations, Dr. Sternberg ranks among the World’s Top 2% Scientists (Stanford University) and the top 5% in the Doximity community for citations. She has delivered more than 835 lectures worldwide, influencing clinical practice, policy, and guidelines in oncology. Her leadership roles in international organizations such as ASCO, ESMO, ECCO, and EORTC demonstrate her far-reaching influence.

Academic Citations

Dr. Sternberg’s research impact is widely recognized. Her publications in high-impact journals such as New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology have shaped global treatment standards. Her works are consistently cited in clinical guidelines, trial protocols, and oncology education, affirming her stature as a thought leader in medical oncology.

Legacy and Future Contributions

Dr. Sternberg’s legacy lies not only in transformative research but also in mentorship. She has nurtured generations of oncologists, fostering innovation and translational research. Currently, she co-leads the Career Development Program in the Bladder SPORE initiative, ensuring the pipeline of future oncology leaders. Her pioneering role in AI in oncology positions her to continue shaping the future of precision medicine, bridging clinical care with technological innovation.

Conclusion

Dr. Cora Sternberg exemplifies the qualities of an Outstanding Scientist—visionary leadership, transformative research, global influence, and unwavering dedication to advancing oncology. Her lifelong contributions to clinical practice, groundbreaking research, academic mentorship, and adoption of emerging technologies ensure her lasting impact on the medical community and future generations of scientists.

Notable Publications

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100

  • Author: homas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Cancers
  • Year: 2025

"The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making

  • Author: Olivier Elemento; Sean Khozin; Cora N. Sternberg
  • Journal: NEJM AI
  • Year: 2025

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100

  • Author: Thomas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Preprint
  • Year: 2025

"Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

  • Author: Scott T. Tagawa; Charlene Thomas; A. Oliver Sartor; Michael Sun; Judith Stangl-Kremser; Mahelia Bissassar; Shankar Vallabhajosula; Sandra Huicochea Castellanos; Jones T. Nauseef; Cora N. Sternberg et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2024

"Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

  • Author: Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N. Sternberg; E. David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2023